|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Muñoz N, Bosch FX, de Sanjosé S, Herrero
R, Castellsagué X, Shah KV, Snijders PJ and Meijer CJ:
International Agency for Research on Cancer Multicenter Cervical
Cancer Study Group: Epidemiologic classification of human
papillomavirus types associated with cervical cancer. N Engl J Med.
348:518–527. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crosbie EJ, Einstein MH, Franceschi S and
Kitchener HC: Human papillomavirus and cervical cancer. Lancet.
382:889–899. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gravitt PE and Rositch AF: HPV
self-testing and cervical cancer screening coverage. Lancet Oncol.
15:128–129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu X, Zhou C, Li R, Deng Y, Zhao L and
Zhai W: Long noncoding RNA AFAP1-AS1 promoted tumor growth and
invasion in cholangiocarcinoma. Cell Physiol Biochem. 42:222–230.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hosseini ES, Meryet-Figuiere M,
Sabzalipoor H, Kashani HH, Nikzad H and Asemi Z: Dysregulated
expression of long noncoding RNAs in gynecologic cancers. Mol
Cancer. 16:1072017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J, Lin Z, Gao Y and Yao T:
Downregulation of long noncoding RNA MEG3 is associated with poor
prognosis and promoter hypermethylation in cervical cancer. J Exp
Clin Cancer Res. 36:52017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liao LM, Sun XY, Liu AW, Wu JB, Cheng XL,
Lin JX, Zheng M and Huang L: Low expression of long noncoding
XLOC_010588 indicates a poor prognosis and promotes proliferation
through upregulation of c-Myc in cervical cancer. Gynecol Oncol.
133:616–623. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun J, Chu H, Ji J, Huo G, Song Q and
Zhang X: Long non-coding RNA HOTAIR modulates HLA-G expression by
absorbing miR-148a in human cervical cancer. Int J Oncol.
49:943–952. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Li P, Zhao W, Yang R, Chen S, Bai Y,
Dun S, Chen X, Du Y, Wang Y, et al: Expression of long non-coding
RNA DLX6-AS1 in lung adenocarcinoma. Cancer Cell Int. 15:482015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zeng X, Hu Z, Ke X, Tang H, Wu B, Wei X
and Liu Z: Long noncoding RNA DLX6-AS1 promotes renal cell
carcinoma progression via miR-26a/PTEN axis. Cell Cycle.
16:2212–2219. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang L, He X, Jin T, Gang L and Jin Z:
Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma
carcinogenesis by modulating miR-203a/MMP-2 pathway. Biomed
Pharmacother. 96:884–891. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
FIGO Committee on Gynecologic Oncology.
Current FIGO staging for cancer of the vagina, fallopian tube,
ovary, and gestational trophoblastic neoplasia. Int J Gynaecol
Obstet. 105:3–4. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong
Q, Qin L, Wu X, Zheng Y, Yang Y, et al: Identification of miRNomes
in human liver and hepatocellular carcinoma reveals miR-199a/b-3p
as therapeutic target for hepatocellular carcinoma. Cancer Cell.
19:232–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ghosh A, Dasgupta D, Ghosh A, Roychoudhury
S, Kumar D, Gorain M, Butti R, Datta S, Agarwal S, Gupta S, et al:
MiRNA199a-3p suppresses tumor growth, migration, invasion and
angiogenesis in hepatocellular carcinoma by targeting VEGFA VEGFR1,
VEGFR2, HGF and MMP2. Cell Death Dis. 8:e27062017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Celià-Terrassa T, Liu DD, Choudhury A,
Hang X, Wei Y, Zamalloa J, Alfaro-Aco R, Chakrabarti R, Jiang YZ,
Koh BI, et al: Normal and cancerous mammary stem cells evade
interferon-induced constraint through the miR-199a-LCOR axis. Nat
Cell Biol. 19:711–723. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
